Abstract

BackgroundSevere malaria is a major contributor of deaths in African children up to five years of age. One valuable tool to support health workers in the management of diseases is clinical practice guidelines (CPGs) developed using robust methods. A critical assessment of the World Health Organization (WHO) and Kenyan paediatric malaria treatment guidelines with quinine was undertaken, with a focus on the quality of the evidence and transparency of the shift from evidence to recommendations.MethodsSystematic reviews of the literature were conducted using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool to appraise included studies. The findings were used to evaluate the WHO and Kenyan recommendations for the management of severe childhood malaria.ResultsThe WHO 2010 malaria guidance on severe malaria in children, which informed the Kenyan guidelines, only evaluated the evidence on one topic on paediatric care using the GRADE tool. Using the GRADE tool, this work explicitly demonstrated that despite the established use of quinine in the management of paediatric cases of severe malaria for decades, low or very low quality evidence of important outcomes, but not critical outcomes such as mortality, have informed national and international guidance on the paediatric quinine dosing, route of administration and adverse effects.ConclusionsDespite the foreseeable shift to artesunate as the primary drug for treatment of severe childhood malaria, the findings reported here reflect that the particulars of quinine therapeutics for the management of severe malaria in African children have historically been a neglected research priority. This work supports the application of the GRADE tool to make transparent recommendations and to inform advocacy efforts for a greater research focus in priority areas in paediatric care in Africa and other low-income settings.

Highlights

  • Eligibility Included articles assessed for inclusion article included

  • Systematic review 2: Should Kenya change its recommendation for treatment of severe malaria in children under 5 of 15mg /kg loading dose followed by 10mg /kg every 12 hours and replace it with the WHO recommended regimen of 20mg /kg loading dose followed by 10mg /kg every 8 hours?

  • Identification articles identified through electronic searches articles assessed for inclusion articles included articles excluded articles excluded

Read more

Summary

Introduction

Systematic review 2: Should Kenya change its recommendation for treatment of severe malaria in children under 5 of 15mg /kg loading dose followed by 10mg /kg every 12 hours and replace it with the WHO recommended regimen of 20mg /kg loading dose followed by 10mg /kg every 8 hours?.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call